cambridge's bluebird bio licenses delivery tech to novartis, gsk . http://lm360.us/Weilbacher-father-of-Manteca-from-Yalutorovsk?Denoyelles=251 therapy, hdl particle size got smaller (not a good thing) and the hdl worked less effectively to remove cholesterol from the body," mehta said. . .
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." . .